TCR engineering of human T cells for immunotherapy of hepatocellular carcinoma

Medicine & Life Sciences

1. T-Cell Antigen Receptor 100%
2. Hepatocellular Carcinoma 52%
3. alpha-Fetoproteins 48%
4. Liver Neoplasms 43%
5. Immunotherapy 38%
6. T-Cell Receptor Genes 29%
7. T-Lymphocytes 27%
8. Clinical Trials 21%
9. human AFP protein 18%
10. Neoplasms 17%
11. HLA-A2 Antigen 14%
12. Cell Engineering 14%
13. varespladib methyl 11%
14. HLA Antigens 11%
15. Centers for Disease Control and Prevention (U.S.) 11%
16. Haplotypes 10%
17. Epitopes 9%
18. Immunization 9%
19. Research Design 8%
20. Cause of Death 8%
21. Cell Count 8%
22. Recurrence 6%
23. Liver 5%
24. Therapeutics 5%
25. Health 5%
26. Incidence 5%